1173 results about "Cycloaddition" patented technology

This invention provides methods for covalently affixing a biomolecule to either a second molecule or a solid surface using 1,3-dipolar cycloaddition chemistry. This invention also provides related methods and compositions.

The invention relates to posttranslational modification of phage-displayed polypeptides. These displayed polypeptides comprise at least one unnatural amino acid, e.g., an aryl-azide amino acid such as p-azido-L-phenylalanine, or an alkynyl-amino acid such as para-propargyloxyphenylalanine, which are incorporated into the phage-displayed fusion polypeptide at a selected position by using an in vivo orthogonal translation system comprising a suitable orthogonal aminoacyl-tRNA synthetase and a suitable orthogonal tRNA species. These unnatural amino acids advantageously provide targets for posttranslational modifications such as azide-alkyne [3+2] cycloaddition reactions and Staudinger modifications.

The present invention provides modified cycloalkyne compounds; and method of use of such compounds in modifying biomolecules. The present invention features a cycloaddition reaction that can be carried out under physiological conditions. In general, the invention involves reacting a modified cycloalkyne with an azide moiety on a target biomolecule, generating a covalently modified biomolecule. The selectivity of the reaction and its compatibility with aqueous environments provide for its application in vivo (e.g., on the cell surface or intracellularly) and in vitro (e.g., synthesis of peptides and other polymers, production of modified (e.g., labeled) amino acids).

The present invention provides modified cycloalkyne compounds; and method of use of such compounds in modifying biomolecules. The present invention features a cycloaddition reaction that can be carried out under physiological conditions. In general, the invention involves reacting a modified cycloalkyne with an azide moiety on a target biomolecule, generating a covalently modified biomolecule. The selectivity of the reaction and its compatibility with aqueous environments provide for its application in vivo (e.g., on the cell surface or intracellularly) and in vitro (e.g., synthesis of peptides and other polymers, production of modified (e.g., labeled) amino acids).

A toner is provided manufactured by a method having the steps: dispersing toner constituents including a resin, in an aqueous medium containing a particulate resin, wherein the resin has a polyester skeleton formed by a ring-opening addition reaction of a cyclic ester with a first compound having an active hydrogen group; and a developer and an image forming method using the toner, and a toner container containing the toner.

The present invention relates to a method for preparing lactone polymers, carbonate polymers, lactone-carbonate block copolymers and lactone-arbonate random copolymers via a ring-opening addition reaction of a lactone monomer, a cyclic carbonate monomer or a mixture thereof using an initiator and in the presence of a specific titanium-type Lewis acid catalyst. The resulting polymers have a molecular weight distribution (Mw/Mn) approximately equal to 1 or a extremely high purity of single-structure components. The polymer molecules range in an oligomer region to a molecular weight of approximately 200,000. The present invention also relates to a method for preparing lactone polymers, carbonate polymers and lactone-carbonate copolymers having a narrow molecular weight distribution and which can be obtained via a continuous polymerisation of a lactone monomer and/or a cyclic carbonate monomer using an initiator in an extruder in the presence of a specific titanium-type Lewis acid catalyst or an aluminium-type Lewis acid catalyst. The present invention also relates to these resulting polymers.

A functional polymer having active and stable functional groups useful for separation or reactive processes in chemical manufacture or analysis is disclosed. The polymer comprises repeat units having structures corresponding to cycloaddition products of polymeric 1-(vinylphenyl)ethylene with electron-poor alkenes. A process for preparing the functional polymer does not require radical reactions or the exclusion of oxygen. The properties of the polymeric matrix produced can be adjusted by modifying the polymer. For example, the polymer particle size and shape, porosity, swellability, surface area, and number, type and distribution of functional groups may be controlled.

The present disclosure provides compositions which may be utilized as adhesives or sealants in medical and surgical applications. The compositions may, in embodiments, be formed from the cycloaddition reaction of a first component possessing at least one azide group with a second component possessing at least one alkyne group.

The use of a selective chemical and bioorthogonal reaction providing a covalent ligation such as the [3+2] cycloaddition, in targeted molecular imaging and therapy is presented, more specifically with interesting applications for pre-targeted imaging or therapy. Current pre-targeted imaging is hampered by the fact that it relies solely on natural/biological targeting constructs (biotin/streptavidin). Size considerations and limitations associated with their endogenous nature severely limit the number of applications. The present invention describes how the use of an abiotic, bio-orthogonal reaction which forms a stable adduct under physiological conditions, by way of a small or undetectable bond, can overcome these limitations.

The present invention relates to methods for the labeling of nucleic acid polymers in vitro and in vivo. Certain methods are provided that include a [3+2] cycloaddition between a nucleotide analogue incorporated into a nucleic acid polymer and a reagent attached to a label. Other methods are provided that include a Staudinger ligation between a nucleotide analogue incorporated into a nucleic acid polymer and a reagent comprising a substituted triarylphosphine attached to a label. Such methods do not require fixation and denaturation and therefore can be applied to the labeling of nucleic acid polymers in living cells and in organisms. Also provided are methods for measuring cellular proliferation. In these methods, the amount of label incorporated into the DNA is measured as an indication of cellular proliferation. The methods of the invention can be used in a wide variety of applications including clinical diagnosis of diseases and disorders in which cellular proliferation is involved, toxicity assays, and as a tool for the study of chromosomes' ultrastructures.

Catalytic processes for the conversion of 2,5-dimethyl furan (DMF) to para-xylene are described. Para-xylene is a key product that is currently obtained commercially from petroleum sources. However, it has now been determined that the cycloaddition of ethylene to DMF provides an alternative route to para-xylene. Advantageously, the DMF starting material for the processes may be synthesized from carbohydrates (e.g., glucose or fructose), thereby providing a pathway that relies at least partly, if not completely, on renewable feedstocks.

The invention discloses a supported ionic liquid catalyst. The supported ionic liquid catalyst is characterized in that imidazole is immobilized onto chloromethylated FDU mesoporous phenolic resin by nucleophilic reaction and reacts with halides containing different functional groups to prepare a mesoporous material supported functional imidazole type ionic liquid catalyst. The preparation of the catalyst comprises the following steps: chloromethylation of a mesoporous material, imidazolation and supporting of ionic liquid. The catalyst is used for synthesizing a cyclic carbonate by cyclic addition reaction of carbon dioxide and an epoxy compound, and the using quantity of the catalyst is 0.1-2mol% of the liquid content of the epoxy compound. Compared with the prior art, a large number of hydroxyl groups exist in the mesoporous material, and the supported ionic liquid catalyst has the double advantages of an inorganic mesoporous material and an organic polymer, as well as large specific surface area, adjustable pore structure, good hydrophobicity and chemical stability, high catalytic activity, good chemical selectivity, easiness in separation and recovery, mild reaction conditions, environmental friendliness and easiness in industrial implementation.

This invention relates to a cycloaddition synthesis method for cyclic carbonates from carbon dioxide and epoxides. In this method, both supported catalysts and cocatalysts are adopted and the cycloaddition reaction is kept at a temperature of 50~200 deg.C and a carbon dioxide pressure of 0.1~10MPa for 0.5~10 hours. Qualitative and quantitative analysis with 6890/5973 chromatography-MS and NMR shows that the product purity is over 99% and the highest separation yield can be up to 95%. Compared to current methods, no organic solvents are adopted in this invention and therefore it is free from the toxicity of bezene, dichloromethane, and so on.

A method for preparing stapled peptides. The stapled peptides, including helical stapled peptides, are prepared according to a photochemically-based method, a [3+2] cycloaddition reaction. The helical stapled peptides exhibit increased helicity, thermal stability and cell permeability.

A process for preparing cyclic carbonate features that catalytic cycloaddition reaction of CO2 on epoxy compound at 100-140 deg.C and 1.5-4.5 MPa for 4-8 hrs under the existance of the catalyst whichis composed of azacyclic compound (halogenated alkylpyridine or halogenated 1,3-dialkyl imidazole) and non-metal halide, and the cocatalyst which is alkali-metal halide or ammonium tetrebutyl bromide. Its advantages are high catalytic activity, smooth reaction condition, easy separation of resultant from catalyst, and cyclic use of catalyst.

Provided are modified cycloalkyne compounds; and methods of use of such compounds in modifying biomolecules. Embodiments include a cycloaddition reaction that can be carried out under physiological conditions. The cycloaddition reaction involves reacting a modified cycloalkyne with an azide moiety on a target biomolecule, generating a covalently modified biomolecule. The selectivity of the reaction and its compatibility with aqueous environments provide for its application in vivo and in vitro.

The invention relates to a preparation method of water-soluble hyperbranched epoxy resin. The method comprises the following steps of: (1) making a polyol serving as a core react with an acid to generate a water-soluble hyperbranched polymer under an appropriate condition; (2) functionally modifying the terminal group of the water-soluble hyperbranched polymer to generate a part of terminal carboxyl group water-soluble hyperbranched polymers; (3) undergoing a ring opening addition reaction on the water-soluble hyperbranched polymer and epoxy chloropropane to generate an addition product; (4) undergoing a ring closing reaction on the addition product under the action of catalyst to generate an epoxy terminal group, and generating a sodium salt through the terminal carboxyl group simultaneously to obtain the water-soluble hyperbranched epoxy resin. The hyperbranched epoxy resin prepared with the method can be dissolved into water to form uniform dispersed system, and has flowing viscosity less than 10 Pa.S, high temperature resistance and high adhesive force.